Whole transcriptome analysis of human erythropoietic cells during ontogenesis suggests a role of VEGFA gene as modulator of fetal hemoglobin and pharmacogenomic biomarker of treatment response to hydroxyurea in β-type hemoglobinopathy patients

MLA

Bassam R. Ali, et al. “Whole Transcriptome Analysis of Human Erythropoietic Cells during Ontogenesis Suggests a Role of VEGFA Gene as Modulator of Fetal Hemoglobin and Pharmacogenomic Biomarker of Treatment Response to Hydroxyurea in β-Type Hemoglobinopathy Patients.” Human Genomics, vol. 11, no. 1. EBSCOhost, https://doi.org/10.1186/s40246-017-0120-8. Accessed 18 Dec. 2024.

APA

Bassam R. Ali, Argyro Sgourou, Vlasia Kastrinou, Alexandra Kourakli, Theodora Katsila, Argiris Symeonidis, George P. Patrinos, Vasiliki Chondrou, Anne John, Alexia Pavlidaki, Adamantia Papachatzopoulou, & Petros Kolovos. (n.d.). Whole transcriptome analysis of human erythropoietic cells during ontogenesis suggests a role of VEGFA gene as modulator of fetal hemoglobin and pharmacogenomic biomarker of treatment response to hydroxyurea in β-type hemoglobinopathy patients. Human Genomics, 11(1). https://doi.org/10.1186/s40246-017-0120-8

Chicago

Bassam R. Ali, Argyro Sgourou, Vlasia Kastrinou, Alexandra Kourakli, Theodora Katsila, Argiris Symeonidis, George P. Patrinos, et al. 2024. “Whole Transcriptome Analysis of Human Erythropoietic Cells during Ontogenesis Suggests a Role of VEGFA Gene as Modulator of Fetal Hemoglobin and Pharmacogenomic Biomarker of Treatment Response to Hydroxyurea in β-Type Hemoglobinopathy Patients.” Human Genomics 11 (1). Accessed December 18. doi:10.1186/s40246-017-0120-8.